2,025 Shares in Astera Labs, Inc. $ALAB Acquired by Sterling Investment Advisors Ltd.

Sterling Investment Advisors Ltd. purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 4th quarter, Holdings Channel reports. The institutional investor purchased 2,025 shares of the company’s stock, valued at approximately $337,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in Astera Labs by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after acquiring an additional 84,365 shares in the last quarter. State Street Corp lifted its position in Astera Labs by 9.1% during the 3rd quarter. State Street Corp now owns 2,339,451 shares of the company’s stock worth $458,065,000 after acquiring an additional 195,992 shares in the last quarter. Amundi lifted its position in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after acquiring an additional 1,319,643 shares in the last quarter. Value Aligned Research Advisors LLC lifted its position in Astera Labs by 16.7% during the 3rd quarter. Value Aligned Research Advisors LLC now owns 1,378,351 shares of the company’s stock worth $269,881,000 after acquiring an additional 197,320 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its position in Astera Labs by 577.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after acquiring an additional 960,899 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently commented on ALAB shares. Royal Bank Of Canada boosted their price target on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. Rothschild & Co Redburn initiated coverage on Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. Citigroup lifted their price objective on Astera Labs from $200.00 to $245.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Needham & Company LLC lifted their price objective on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Finally, Barclays lifted their price objective on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $306.88 on Tuesday. Astera Labs, Inc. has a twelve month low of $84.78 and a twelve month high of $315.81. The company has a market capitalization of $52.60 billion, a price-to-earnings ratio of 207.35, a price-to-earnings-growth ratio of 4.06 and a beta of 3.35. The business has a 50 day simple moving average of $174.13 and a 200-day simple moving average of $160.46.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same period in the previous year, the business earned $0.33 EPS. The business’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insider Transactions at Astera Labs

In other news, COO Sanjay Gajendra sold 280,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $249.19, for a total value of $69,773,200.00. Following the completion of the sale, the chief operating officer directly owned 615,000 shares in the company, valued at approximately $153,251,850. The trade was a 31.28% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 28,737 shares of the business’s stock in a transaction that occurred on Tuesday, May 19th. The shares were sold at an average price of $249.62, for a total value of $7,173,329.94. Following the completion of the sale, the chief executive officer owned 3,789,232 shares of the company’s stock, valued at $945,868,091.84. This trade represents a 0.75% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,915,461 shares of company stock valued at $358,508,976 over the last 90 days. Insiders own 12.50% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.